Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
|
|
CytoDyn Inc. (CYDY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
4
| Arman Arvin Cyrus (President) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 434,782 shares
@ $0
Granted 434,782 warrants
@ $0.5, valued at
$217.4k
|
|
| 11/30/2022 |
4
| Migliarese Antonio (CFO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 12,008 shares
@ $0
Granted 4,585,536 options to buy
@ $0.35, valued at
$1.6M
|
|
| 11/30/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 16,927 shares
@ $0
Granted 2,315,439 options to buy
@ $0.35, valued at
$810.4k
|
|
| 11/17/2022 |
4
| Migliarese Antonio (CFO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 10,807 shares
@ $0 |
|
| 11/17/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 15,234 shares
@ $0 |
|
| 11/17/2022 |
4
| Ray Nitya G. (Chief Technology Officer) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 13,671 shares
@ $0 |
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Ray Nitya G. (Chief Technology Officer) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 12,428 shares
@ $0 |
|
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 13,849 shares
@ $0 |
|
| 10/04/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 18,793 shares
@ $0 |
|
| 10/04/2022 |
4
| Ray Nitya G. (Chief Technology Officer) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 13,020 shares
@ $0 |
|
| 10/04/2022 |
4
| Migliarese Antonio (CFO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 10,292 shares
@ $0 |
|
| 09/22/2022 |
4
| Migliarese Antonio (CFO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 630,222 options to buy
@ $0.58, valued at
$365.5k
|
|
| 09/22/2022 |
4
| Arman Arvin Cyrus (President) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 646,552 shares
@ $0
Granted 1,575,557 options to buy
@ $0.58, valued at
$913.8k
|
|
| 09/19/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 9,457 shares
@ $0 |
|
| 09/19/2022 |
4
| Ray Nitya G. (Chief Technology Officer) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 8,965 shares
@ $0 |
|
| 09/19/2022 |
4
| Migliarese Antonio (CFO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 7,086 shares
@ $0 |
|
| 09/08/2022 |
4
| Brunke Karen J (Director) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 37,500 options to buy
@ $0.5, valued at
$18.8k
Granted 247,111 options to buy
@ $0.5, valued at
$123.6k
|
|
| 09/08/2022 |
4
| Ndhlovu Lishomwa C (Director) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 112,500 options to buy
@ $0.5, valued at
$56.3k
Granted 50,000 options to buy
@ $0.5, valued at
$25k
Granted 247,111 options to buy
@ $0.5, valued at
$123.6k
|
|
| 09/08/2022 |
4
| Dunlap Ryan (Director) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 185,333 options to buy
@ $0.5, valued at
$92.7k
|
|
| 09/08/2022 |
4
| Urbach Tanya Durkee (Director) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 112,500 options to buy
@ $0.5, valued at
$56.3k
Granted 247,111 options to buy
@ $0.5, valued at
$123.6k
|
|
| 09/02/2022 |
4
| Migliarese Antonio (CFO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 8,313 shares
@ $0 |
|
| 09/02/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 11,094 shares
@ $0 |
|
| 09/02/2022 |
4
| Ray Nitya G. (Chief Technology Officer) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 10,516 shares
@ $0 |
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 6,950 shares
@ $0 |
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Migliarese Antonio (CFO & Interim President) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 5,614 shares
@ $0 |
|
| 08/04/2022 |
4
| Kelly Scott A. (CMO) has filed a Form 4 on CytoDyn Inc.|
Txns:
| Granted 7,492 shares
@ $0 |
|
|
|
|